中科通达(688038) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥55,565,603.38, representing a year-on-year increase of 102.44%[6]. - Total revenue for Q1 2023 reached ¥55,565,603.38, a significant increase of 102.5% compared to ¥27,448,165.74 in Q1 2022[19]. - Operating costs for Q1 2023 were ¥65,695,880.36, up 72.3% from ¥38,166,043.69 in Q1 2022[19]. - Net loss for Q1 2023 was ¥1,752,827.36, an improvement from a net loss of ¥6,922,438.57 in Q1 2022[21]. - Basic and diluted earnings per share for Q1 2023 were both -¥0.02, compared to -¥0.06 in Q1 2022[21]. Cash Flow - The net profit attributable to shareholders was a loss of ¥1,752,827.36, with a significant increase in cash flow from operating activities by ¥40,438,600 compared to the same period last year[6][11]. - The company reported a net cash flow from operating activities of -¥19,540,075.46, indicating challenges in cash generation despite revenue growth[6]. - Cash inflow from operating activities was ¥89,751,082.43 in Q1 2023, up from ¥47,870,036.00 in Q1 2022[22]. - Cash outflow from operating activities totaled ¥109,291,157.89 in Q1 2023, slightly higher than ¥107,848,729.69 in Q1 2022[22]. - The net increase in cash and cash equivalents was -$51.79 million, compared to -$81.27 million in Q1 2022[23]. - The ending balance of cash and cash equivalents was $52.81 million, up from $31.42 million in the same quarter last year[23]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,318,505,358.79, showing a slight increase of 0.53% from the end of the previous year[7]. - Total liabilities decreased from ¥1,311,493,773.16 to ¥1,318,505,358.79, reflecting a growth of approximately 0.54%[17]. - Total liabilities increased to ¥599,036,729.06 as of March 31, 2023, compared to ¥590,461,828.30 at the end of 2022[18]. - Shareholders' equity decreased to ¥719,468,629.73 from ¥721,031,944.86 as of December 31, 2022[18]. Research and Development - Research and development expenses totaled ¥6,914,875.50, accounting for 12.44% of operating revenue, a decrease of 16.61 percentage points year-on-year[7]. - The company experienced a decrease in R&D investment by 13.29% compared to the previous year, indicating a potential shift in strategic focus[7]. - The company has not disclosed any new product or technology developments in this quarter[15]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,617, with the largest shareholder holding 16.30% of the shares[13]. Other Financial Metrics - The weighted average return on net assets was -0.24%, an increase of 0.7 percentage points compared to the previous year[7]. - The diluted earnings per share for the period was -¥0.02, reflecting ongoing financial pressures[7]. - The company incurred a credit impairment loss of ¥7,187,478.93 in Q1 2023, compared to ¥1,047,785.60 in Q1 2022[20]. - The company reported a decrease in long-term borrowings to ¥140,450,000.00 from ¥147,550,000.00 as of December 31, 2022[18]. - The company is focusing on improving cash flow management and reducing losses in the upcoming quarters[11].